HKD 0.18
(-1.1%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 11.53 Million HKD | -5.02% |
2022 | 12.14 Million HKD | -22.85% |
2021 | 15.73 Million HKD | -15.92% |
2020 | 18.71 Million HKD | 6.12% |
2019 | 17.63 Million HKD | 0.0% |
2018 | - HKD | 0.0% |
2017 | - HKD | -100.0% |
2016 | 6.96 Million HKD | -42.26% |
2015 | 12.05 Million HKD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | - HKD | -100.0% |
2024 Q2 | 10.39 Million HKD | 0.0% |
2023 Q3 | - HKD | -100.0% |
2023 Q1 | - HKD | -100.0% |
2023 FY | 11.53 Million HKD | -5.02% |
2023 Q2 | 9.76 Million HKD | 0.0% |
2023 Q4 | 11.53 Million HKD | 0.0% |
2022 Q2 | 14.35 Million HKD | 0.0% |
2022 Q1 | - HKD | -100.0% |
2022 FY | 12.14 Million HKD | -22.85% |
2022 Q4 | 12.14 Million HKD | 0.0% |
2022 Q3 | - HKD | -100.0% |
2021 Q2 | 17.49 Million HKD | 0.0% |
2021 Q1 | - HKD | -100.0% |
2021 FY | 15.73 Million HKD | -15.92% |
2021 Q4 | 15.73 Million HKD | 0.0% |
2020 FY | 18.71 Million HKD | 6.12% |
2020 Q4 | 18.71 Million HKD | 0.0% |
2020 Q1 | - HKD | -100.0% |
2020 Q2 | 15.62 Million HKD | 0.0% |
2019 Q2 | 19.62 Million HKD | 0.0% |
2019 Q1 | - HKD | 0.0% |
2019 Q4 | 17.63 Million HKD | 0.0% |
2019 FY | 17.63 Million HKD | 0.0% |
2018 Q4 | - HKD | 0.0% |
2018 FY | - HKD | 0.0% |
2018 Q2 | - HKD | 0.0% |
2018 Q1 | - HKD | 0.0% |
2017 Q1 | - HKD | -100.0% |
2017 Q4 | - HKD | 0.0% |
2017 FY | - HKD | -100.0% |
2016 Q4 | 6.96 Million HKD | 0.0% |
2016 FY | 6.96 Million HKD | -42.26% |
2015 FY | 12.05 Million HKD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 186.28 Million HKD | 93.81% |
Innovative Pharmaceutical Biotech Limited | 917.44 Million HKD | 98.743% |
China Overseas Nuoxin International Holdings Limited | 49.93 Million HKD | 76.907% |
Prosperous Future Holdings Limited | 20.89 Million HKD | 44.812% |
Huasheng International Holding Limited | 338.39 Million HKD | 96.592% |
Fourace Industries Group Holdings Limited | 3.24 Million HKD | -255.895% |
Evergreen Products Group Limited | 615 Million HKD | 98.125% |
EC Healthcare | 1.6 Billion HKD | 99.281% |
Ming Fai International Holdings Limited | 57.56 Million HKD | 79.967% |
Blue Moon Group Holdings Limited | 158.89 Million HKD | 92.743% |
SuperRobotics Holdings Limited | 138.44 Million HKD | 91.671% |
Hyfusin Group Holdings Limited | 18.36 Million HKD | 37.205% |